Medicare Enrolled

Dr. Wendy Huhn, M.D.

Endocrinology · Orlando, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3113 LAWTON RD, Orlando, FL 32803
4078943241
In practice since 2006 (19 years)
NPI: 1720099070 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Huhn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Huhn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Huhn

Dr. Wendy Huhn is an endocrinology in Orlando, FL, with 19 years in practice. Based on federal Medicare data, Dr. Huhn performed 2,362 Medicare services across 680 unique beneficiaries.

Between the years covered by Open Payments, Dr. Huhn received a total of $15,468 from 61 pharmaceutical and/or device companies across 779 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Huhn is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 25% volume in FL$ $15,468 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,362
Medicare services
Top 25% in FL for endocrinology
680
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~124 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)1,320$17$50
Office visit, established patient (30-39 min)570$83$338
Blood glucose (sugar) test performed by hand-held instrument231$3$10
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report109$26$128
Office visit, established patient, complex (40-54 min)46$120$458
Drug injection, under skin or into muscle36$9$73
Hemoglobin A1c test (diabetes monitoring)19$10$37
New patient office visit (45-59 min)19$109$498
Ultrasound scan of head and neck soft tissue12$74$342
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,468
Total received (2018-2024)
Avg $2,210/year across 7 years
Top 22% in FL for endocrinology
61
Companies
779
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,468 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$798
2023
$537
2022
$1,505
2021
$2,762
2020
$3,756
2019
$3,692
2018
$2,418

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic MiniMed, Inc.
$1,993
Novo Nordisk Inc
$1,264
Tosoh Bioscience, Inc.
$1,121
SANOFI-AVENTIS U.S. LLC
$927
Amgen Inc.
$845
Lilly USA, LLC
$754
AstraZeneca Pharmaceuticals LP
$695
IBSA Pharma Inc.
$670
Boehringer Ingelheim Pharmaceuticals, Inc.
$597
Dexcom, Inc.
$552
Radius Health, Inc.
$492
Abbott Laboratories
$412
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$403
Medtronic, Inc.
$392
Xeris Pharmaceuticals, Inc.
$364
Horizon Therapeutics plc
$294
Merck Sharp & Dohme Corporation
$275
Corcept Therapeutics
$259
Alexion Pharmaceuticals, Inc.
$243
Janssen Pharmaceuticals, Inc
$204
MannKind Corporation
$200
Shire North American Group Inc
$197
Tandem Diabetes Care, Inc.
$194
Insulet Corporation
$181
AbbVie Inc.
$140
Mannkind Corporation
$139
AbbVie, Inc.
$123
Ipsen Biopharmaceuticals, Inc
$120
Amneal Pharmaceuticals LLC
$118
LifeScan, Inc.
$108
PFIZER INC.
$102
Nevro Corp.
$96
DEXCOM, INC.
$85
Antares Pharma, Inc.
$83
GRT US Holding, Inc.
$72
Bayer Healthcare Pharmaceuticals Inc.
$71
Averitas Pharma Inc.
$64
Bayer HealthCare Pharmaceuticals Inc.
$62
Zealand Pharma US, Inc.
$58
ABBVIE INC.
$42
Ferring Pharmaceuticals Inc.
$38
Roche Diabetes Care, Inc.
$32
Amarin Pharma Inc.
$29
Aytu BioScience, Inc
$29
Merck Sharp & Dohme LLC
$29
Gemini Laboratories, LLC
$29
Kyowa Kirin, Inc.
$29
Ascendis Pharma Inc
$28
Strongbridge US INC.
$23
Ascensia Diabetes Care Us Inc.
$21
Companion Medical, Inc.
$20
Becton, Dickinson and Company
$20
RECORDATI_RARE_DISEASES_INC.
$19
Endo Pharmaceuticals Inc.
$17
Valeritas, Inc.
$15
CeQur Corporation
$14
Acerus Pharmaceuticals Corporation
$13
Clarus Therapeutics Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Senseonics, Incorporated
$12
Alfasigma USA, Inc.
$11
Top 3 companies account for 28.3% of total payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Aimovig · BASAGLAR · BD Nano · CYCLOSET · Cables · CeQur Simplicity · Creon · Crysvita · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · G8 Column · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Kits and Accessories · Korlym · LYUMJEV · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · Natesto · Norditropin · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Otrexup · Ozempic · Prolia · QUTENZA · Qutenza · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Software · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · ZOMACTON · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $655 per 100 Medicare services performed
Looking for a endocrinology in Orlando?
Compare endocrinologys in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
60
Per 100K population
4.2
County median income
$77,011
Nearest hospital
ADVENTHEALTH ORLANDO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Huhn is a clinical cardiology specialist, with above-average Medicare volume (top 25% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Huhn experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Huhn performed 1,320 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Huhn receive payments from pharmaceutical companies?
Yes. Dr. Huhn received a total of $15,468 from 61 companies across 779 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Huhn's costs compare to other endocrinologys in Orlando?
Dr. Huhn's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Huhn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →